Geburtsdatum
Alter
15.07.1992 (Alter: 31)
31
(15.07.1992)
Draft
Saison 14 / #23 (CLE)
Saison 14 / #23
(CLE)
Career Earnings
360.80 Mio
Gesamt
TOT
18
13105
7050
2290
1092
479
157
375
1821
1821
952
2227
566
652
403
630
1190
494
377
24
15
0
6331
Schnitt
AVG
26.5
14.3
4.6
2.2
1.0
0.3
0.8
3.7
7.0
1.9
4.5
1.1
1.3
0.8
1.3
2.4
52.9%
42.7%
86.8%
27.4
20.9
1.3
0.8
0.0
12.8
20.7%
17.9
2.9
0.76
0.25
Career High
High
36
55
12
8
4
5
5
12
24
15
22
8
10
5
6
39
Gesamt
TOT
10
1065
631
155
85
28
12
36
0
94
94
194
69
77
21
39
-61
39
21
0
1
0
549
Schnitt
AVG
27.3
16.2
4.0
2.2
0.7
0.3
0.9
3.6
7.3
2.4
5.0
1.8
2.0
0.5
1.0
-1.6
49.1%
48.5%
89.6%
3.9
2.1
0.0
0.1
0.0
14.1
0.0%
18.4
0.0
0.00
0.00
Career High
High
32
22
7
5
2
1
2
5
11
4
7
9
10
2
2
18
Gesamt
TOT
681
208
140
83
26
10
18
83
153
5
29
26
34
26
36
-31
26
28
0
0
0
215
Schnitt
AVG
26.2
8.0
5.4
3.2
1.0
0.4
0.7
3.2
5.9
0.2
1.1
1.0
1.3
1.0
1.4
-1.2
54.2%
17.2%
76.5%
8.3
9.0%
13.4
4.61
0.72
0.28
Season High
High
31
20
10
6
4
3
2
7
10
1
3
6
6
4
6
27
77.8%
50.0%
50.0%
15
16.7%
31.8
6.00
3.00
1.50
38
83
CLE
11.0
29.2
8.8
3.8
1.5
1.2
0.1
0.6
1.8
3.7
1.5
3.9
0.7
0.8
0.4
1.2
0.4
49.3%
37.8%
87.5%
19
19
0
0
0
8.6
13.6%
10.3
2.55
1.05
0.09
37
81
IND
26.0
28.2
10.2
3.8
1.9
1.0
0.0
0.9
2.5
3.9
1.5
3.2
0.5
0.7
1.0
1.2
-2.4
64.7%
48.2%
82.4%
26
24
1
0
0
8.3
12.9%
13.9
2.17
0.90
0.00
36
82
IND
26.0
26.4
21.9
4.3
1.7
0.5
0.1
0.5
4.5
9.0
3.1
6.4
3.4
3.7
0.9
1.7
1.3
50.2%
49.1%
93.0%
27
27
1
1
0
17.6
28.5%
25.0
3.29
0.28
0.06
35
82
IND
26.0
21.9
9.2
3.6
2.0
0.9
0.0
1.0
2.2
4.6
1.2
3.0
1.1
1.5
0.6
0.8
5.1
49.2%
40.7%
76.7%
29
0
2
0
0
9.1
17.9%
13.7
2.04
1.04
0.00
34
85
TOR
26.0
25.6
17.8
4.0
2.5
0.9
0.4
0.9
4.7
8.6
2.5
4.8
0.9
1.0
0.6
0.8
-1.8
54.1%
52.6%
88.9%
28
10
3
0
0
14.8
26.4%
22.9
2.76
1.09
0.43
33
85
TOR
26.0
26.8
14.0
4.2
1.8
0.8
0.2
0.6
3.9
8.0
1.9
4.8
0.4
0.4
1.0
0.7
1.9
48.5%
39.7%
100.0%
25
26
2
0
0
13.7
23.1%
15.4
2.88
1.12
0.29
32
85
LAC
25.0
25.8
23.9
3.4
1.8
0.7
0.4
0.8
3.7
6.2
5.0
8.4
1.6
1.6
0.4
1.3
16.2
59.4%
59.8%
97.5%
25
25
2
0
0
16.1
27.0%
30.8
2.30
0.52
0.27
31
84
POR
25.0
29.5
14.9
4.1
2.7
1.0
0.1
0.7
4.5
7.9
1.5
4.5
1.4
1.4
0.8
1.5
-0.8
57.0%
32.8%
97.4%
27
27
2
0
0
13.8
20.0%
16.1
3.65
0.68
0.10
30
85
DAL
25.0
27.6
16.5
5.5
2.5
1.0
0.5
1.0
4.5
8.5
2.2
6.1
1.0
1.3
0.9
1.5
-1.3
52.3%
36.1%
78.8%
26
27
2
2
0
16.1
26.0%
18.0
2.60
0.66
0.32
29
85
MIL
25.0
27.9
18.0
6.5
2.5
1.0
0.3
0.7
3.8
7.8
3.1
7.8
1.1
1.2
1.0
1.5
2.3
49.0%
39.4%
90.9%
45
45
3
5
0
16.8
22.0%
20.1
3.50
0.71
0.23
28
86
BOS
25.0
26.1
15.8
4.7
1.5
0.9
0.8
0.6
3.6
6.2
2.7
6.4
0.7
0.8
0.4
1.3
7.9
58.1%
42.2%
87.5%
40
39
2
0
0
13.6
24.0%
19.8
2.50
0.69
0.62
27
82
ORL
12.0
28.0
14.8
5.5
3.3
1.0
0.4
1.0
5.2
9.4
1.1
2.6
1.2
1.7
1.1
1.5
5.6
55.4%
42.2%
70.4%
42
42
4
1
0
13.7
22.0%
18.9
3.31
0.67
0.27
26
82
ORL
12.0
30.1
18.4
5.7
3.1
1.5
0.5
1.1
5.6
10.8
1.7
3.7
2.1
2.3
1.6
1.8
1.0
51.8%
45.9%
90.8%
33
0
0
4
0
16.6
24.0%
21.3
2.83
0.85
0.29
25
78
ORL
12.0
26.2
8.0
5.4
3.2
1.0
0.4
0.7
3.2
5.9
0.2
1.1
1.0
1.3
1.0
1.4
-1.2
54.2%
17.2%
76.5%
26
28
0
0
0
8.3
9.0%
13.4
4.61
0.72
0.28
24
80
SAC
12.0
28.9
10.7
5.7
2.0
1.4
0.4
0.6
3.8
7.2
0.5
1.9
1.6
1.7
1.1
1.1
1.7
52.8%
27.6%
92.3%
15
0
0
1
0
10.5
13.0%
14.5
3.33
1.24
0.35
23
78
CLE
15.4
14.5
5.2
1.8
0.5
0.5
0.3
0.2
1.3
2.2
0.7
1.3
0.5
0.7
0.3
1.3
-1.5
61.5%
50.0%
75.0%
6
0
0
0
0
4.0
1.0%
13.1
3.00
0.38
0.25
21
79
DEN
8.0
20.0
4.9
2.2
1.7
0.7
0.3
0.7
1.2
3.4
0.7
3.3
0.4
0.5
0.2
0.9
-4.0
34.7%
22.0%
78.6%
28
11
0
0
0
7.5
0.0%
5.1
2.53
0.76
0.28
20
80
GSW
8.0
25.7
10.1
5.3
1.3
1.3
0.2
0.4
2.8
5.3
1.4
2.6
0.5
0.5
0.8
1.1
5.6
52.4%
53.6%
92.9%
27
27
0
1
0
8.5
0.0%
15.5
2.92
1.13
0.20
2018-01-06
01-06
ORL
SAS
29
8
8
6
1
0
1
3
5
0
1
2
2
0
1
10
50.0%
0.0%
100.0%
x
8
9.1%
15.6
6.00
1.00
0.00
2017-12-30
12-30
ORL
TOR
27
20
3
5
0
0
0
7
8
1
3
3
3
1
0
12
72.7%
33.3%
100.0%
x
12
13.8%
31.0
--
--
--
2017-12-27
12-27
ORL
PHX
30
8
7
3
1
0
0
4
4
0
0
0
0
2
2
6
100.0%
--
--
x
4
4.8%
17.2
--
0.50
0.00
2017-12-24
12-24
ORL
TOR
26
9
10
6
1
0
0
4
7
0
1
1
1
2
1
5
50.0%
0.0%
100.0%
x
8
9.0%
21.6
--
1.00
0.00
2017-12-21
12-21
ORL
CHI
28
8
4
4
0
3
1
3
6
0
1
2
2
1
2
-10
42.9%
0.0%
100.0%
x
9
9.8%
13.3
4.00
0.00
1.50
2017-12-17
12-17
ORL
UTA
26
6
7
5
0
1
0
2
4
0
0
2
2
2
1
-9
50.0%
--
100.0%
x
5
5.5%
17.1
--
0.00
1.00
2017-12-16
12-16
ORL
MIA
27
10
9
2
1
0
1
4
9
0
0
2
2
1
0
2
44.4%
--
100.0%
x
11
13.6%
14.4
2.00
--
--
2017-12-11
12-11
ORL
DET
27
5
10
3
1
0
0
2
5
0
0
1
2
4
0
-8
40.0%
--
50.0%
x
6
6.8%
14.9
--
--
--
2017-12-10
12-10
ORL
IND
25
4
4
5
1
0
2
2
4
0
1
0
0
1
5
2
40.0%
0.0%
--
x
7
7.7%
5.7
2.50
0.20
0.00
2017-12-09
12-09
ORL
PHI
28
17
6
2
1
1
2
7
9
1
3
0
0
0
6
7
66.7%
33.3%
--
x
14
16.7%
18.5
1.00
0.17
0.17
2017-12-09
12-09
ORL
MIL
27
6
6
4
0
1
0
3
6
0
1
0
0
1
0
10
42.9%
0.0%
--
x
7
7.6%
12.1
--
--
--
2017-12-08
12-08
ORL
CLE
31
8
2
1
3
0
1
4
10
0
1
0
0
0
1
-23
36.4%
0.0%
--
x
12
12.9%
6.0
1.00
3.00
0.00
2017-11-27
11-27
ORL
DAL
29
3
4
4
0
0
1
1
2
0
0
1
2
0
1
-9
50.0%
--
50.0%
x
4
5.2%
5.7
4.00
0.00
0.00
2017-11-20
11-20
ORL
WAS
29
2
7
4
0
0
1
1
2
0
2
0
0
1
1
-24
25.0%
0.0%
--
x
5
5.6%
4.7
4.00
0.00
0.00
2017-11-19
11-19
ORL
MIL
23
6
4
4
1
1
0
3
4
0
1
0
0
0
3
27
60.0%
0.0%
--
x
5
6.0%
15.2
--
0.33
0.33
2017-11-18
11-18
ORL
IND
30
10
6
3
2
0
1
3
7
1
3
1
3
0
0
-11
40.0%
33.3%
33.3%
x
12
14.7%
11.5
3.00
--
--
2017-11-13
11-13
ORL
NOP
24
3
4
5
0
1
1
0
3
1
2
0
0
1
0
1
20.0%
50.0%
--
x
6
7.1%
7.7
5.00
--
--
2017-11-11
11-11
ORL
PHI
18
12
5
4
1
0
0
5
10
0
2
2
2
1
1
7
41.7%
0.0%
100.0%
x
13
14.9%
24.2
--
1.00
0.00
2017-11-05
11-05
ORL
GSW
28
4
4
2
1
0
1
2
2
0
0
0
0
0
2
8
100.0%
--
--
x
3
3.2%
7.9
2.00
0.50
0.00
2017-11-01
11-01
ORL
CLE
28
5
5
0
4
2
0
2
6
0
1
1
2
2
0
-12
28.6%
0.0%
50.0%
x
8
8.7%
12.5
--
--
--
2017-10-30
10-30
ORL
HOU
27
4
4
4
1
0
1
2
6
0
3
0
1
1
3
-7
22.2%
0.0%
0.0%
x
10
12.3%
1.5
4.00
0.33
0.00
2017-10-29
10-29
ORL
CHI
31
6
4
3
0
0
1
3
8
0
0
0
0
1
1
-6
37.5%
--
--
x
9
10.3%
4.8
3.00
0.00
0.00
2017-10-23
10-23
ORL
LAC
24
17
6
1
4
0
2
7
8
0
1
3
3
3
3
5
77.8%
0.0%
100.0%
x
12
13.3%
31.8
0.50
1.33
0.00
2017-10-22
10-22
ORL
POR
23
4
6
0
1
0
0
2
6
0
0
0
0
0
1
-1
33.3%
--
--
x
6
5.7%
5.1
--
1.00
0.00
2017-10-22
10-22
ORL
OKC
15
6
2
0
1
1
0
3
3
0
1
0
0
0
0
4
75.0%
0.0%
--
x
4
3.9%
18.9
--
--
--
2017-10-22
10-22
ORL
LAL
21
16
4
2
1
0
1
5
10
0
1
6
6
2
1
-18
45.5%
0.0%
100.0%
x
15
14.4%
25.2
2.00
1.00
0.00